Andrew Saik - 21 Mar 2023 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
EVP & Chief Financial Officer
Signature
/s/ Rocco Venezia
Issuer symbol
N/A
Transactions as of
21 Mar 2023
Net transactions value
-$12,899
Form type
4
Filing time
23 Mar 2023, 16:01:09 UTC
Previous filing
31 Jan 2023
Next filing
23 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $12,899 -909 -1.3% $14.19 70,081 21 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.